Rianlon

Rianlon is a global leader in the production of anti-aging additives for polymer materials that has strategically expanded into the life sciences sector. Through its dedicated Life Science business unit and the acquisition of Tianjin U-Syn, the company provides high-quality raw materials and CDMO services for nucleic acid drugs, including phosphoramidites and nucleoside monomers. Rianlon operates multiple global production bases and R&D centers, positioning itself as a critical supplier in the pharmaceutical supply chain for mRNA and siRNA therapeutics. The company is publicly traded on the Shenzhen Stock Exchange and serves a diverse range of industries from plastics to biotechnology. Its expansion into life sciences leverages its expertise in large-scale chemical synthesis and high-purity purification technologies.